Immune priming to accelerate/enhance immune response through administration of natural immune modulator
AssigneeZIVO Bioscience, Inc.
InventorsAmy E. Steffek, Andrew A. Dahl, William P. Pfund
Life of this patent
Estimating the term…
Loading patent…
AssigneeZIVO Bioscience, Inc.
InventorsAmy E. Steffek, Andrew A. Dahl, William P. Pfund
Estimating the term…
A method and compound for altering the status of both innate and adaptive immune pathways in both animals and humans are disclosed. The status alteration results in the immune response being primed whereby an accelerated and more robust response is generated when the animal or human is challenged by pathogens that lead to a wide range of disease states. The disclosed method utilizes a compound derived from a lipopolysaccharide (LPS) of gram-negative bacteria. The compound itself is a natural product with no observed adverse environmental impact. By priming the immune pathways according to the disclosed inventive concept, the severity of various disease states can be reduced, can be resolved more quickly, or can be avoided entirely.
A method of altering immunometabolism in early life stage animals comprising:
A method of priming an immune response in an animal for the prevention of disease, the method comprising feeding the animal an effective amount of a composition comprising a lipopolysaccharide derived from Gram-negative bacteria, the method including the step of feeding the animal the effective amount of the composition commencing on Day 1 of the life of the animal;
A method of priming the immune system of an animal against coccidiosis, comprising administering feed including a non-antibiotic composition in the form of a lipopolysaccharide derived from Gram-negative bacteria in an amount effective to minimize the risk of the animal becoming infected with coccidiosis, the composition being fed to the animal in an amount providing from about 0.5 lbs. composition per ton of finished feed to about 11.0 lbs. composition per ton of finished feed.
A composition for the treatment of coccidiosis in animals, the composition comprising effective amounts of a feed ingredient including a biomass selected from the group consisting of one or more of a supernatant, symbiont bacteria, bacterial biomass, and bacterial fermentate,
Dependencies are inferred from the claim text.